No live calls today · full consensus board · no graded calls yet
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Recent news
| 2026-10-21 | 4 - Rapport Therapeutics, Inc. (0002012593) (Issuer) · sec_edgar_current |
| 2026-10-22 | Analysts’ Top NA Picks: Rapport Therapeutics, Inc. (RAPP), SpaceX (SPCX) · The Globe and Mail |
| 2026-10-21 | Rapport Therapeutics Enters Oversold Territory (RAPP) · nasdaq_markets |
| 2026-10-21 | $RAPP with 478mil in cash, almost $10/sh. Why is it manipulated so you give up your shares. Time to accumulate. · stocktwits |
| 2026-10-21 | $RAPP they are def buying · stocktwits |
| 2026-10-21 | $RAPP Who owns $RAPP? A look at Rapport Therapeutics’ major institutional investors: • Third Rock Ventures: 7.25M shares — 15.11% • Fidelity (FMR): 7.17M shares — 14.95% • ARCH Venture Partners: 3.73M shares — 7.77% • Capital Research & Management: 3.47M shares — 7.24% • Bla · stocktwits |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。